Indications and Usage
NovoSeven® RT (Coagulation Factor VIIa [Recombinant]) is a coagulation factor indicated for:
• Treatment of bleeding episodes and peri-operative management in adults and children with hemophilia A or B
with inhibitors, congenital Factor VII (FVII) deficiency, and Glanzmann’s thrombasthenia with refractoriness Ѽ)